Vulnerability · CVE-2023-52076
mate-desktop atril Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
Published Dec 8, 2025 · catalog updated Dec 8, 2025 · mate-desktop atril Improper Limitation
Patch now
CVE-2023-52076 is in the CISA known-exploited catalog. Confirm mate-desktop atril Improper Limitation against the vendor advisory and apply that fix. The CVSS score does not change the priority.
Gaps on this record
- The stored product name is a package slug. The name on this page is taken from the title (mate-desktop atril Improper Limitation).
- No version range is stored. A customer cannot check an installed version against this record.
- Severity
- Unknown—
- Known exploitation
- CISA KEV and VulnCheck KEV
- EPSS
- 1.08%
- Remediation
- Remediation guidance
- Affected products
- vendor mate-desktop atril
Atril Document Viewer is the default document reader of the MATE desktop environment for Linux. A path traversal and arbitrary file write vulnerability exists in versions of Atril prior to 1.26.2. This vulnerability is capable of writing arbitrary files anywhere on the filesystem to which the user opening a crafted document has access. The only limitation is that this vulnerability cannot be exploited to overwrite existing files, but that doesn't stop an attacker from achieving Remote Command Execution on the target system. Version 1.26.2 of Atril contains a patch for this vulnerability.
Are you affected?
Enter the version you run. The result uses only the ranges stored on this record.
The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.
- vendor mate-desktop atrilversion unspecified
How to fix CVE-2023-52076
Recommended remediation
Apply remediations or mitigations per vendor instructions or discontinue use of the product if remediation or mitigations are unavailable.
Official advisories
What to do
Three questions, each answered from this record only. Confirm the vendor advisory before you patch.
Should you patch?
CVE-2023-52076 is in the CISA known-exploited catalog. Confirm mate-desktop atril Improper Limitation against the vendor advisory and apply that fix. The CVSS score does not change the priority.
Which versions are affected?
Affected version ranges are not on this record. Apply remediations or mitigations per vendor instructions or discontinue use of the product if remediation or mitigations are unavailable.
What should an analyst verify?
No weakness class is stored. EPSS 1.08%. The CISA KEV listing is the exploitation evidence. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.
Code
The project this record applies to. Exploit listings stay in References.
No public source repository is identified for this product.
Timeline
Detection, updates, and resolution for this record.
Dec 8, 2025 · VulnCheck KEV
Detected
Atril Document Viewer is the default document reader of the MATE desktop environment for Linux. A path traversal and arbitrary file write vulnerability exists in versions of Atril prior to 1.26.2. This vulnerability is capable of writing arbitrary files anywhere on the filesystem to which the user opening a crafted document has access. The only limitation is that this vulnerability cannot be explo
Dec 8, 2025 · CISA KEV
Known exploited
Apply remediations or mitigations per vendor instructions or discontinue use of the product if remediation or mitigations are unavailable.
Sources
- CVE.orgVulnerability recordCVE-2023-52076
Official CVE identifier
cve.org - FIRST EPSSExploitation probabilityCVE-2023-52076
30-day exploitation probability 1.1%
first.org - VulnCheck KEVConfirmed exploitationCVE-2023-52076
Atril Document Viewer is the default document reader of the MATE desktop environment for Linux. A path traversal and arbitrary file write vulnerability exists in versions of Atril prior to 1.26.2. This vulnerability is capable of writing arbitrary files anywhere on the filesystem
vulncheck.com
References
Freshness
Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.